Recent Updates
Recently added Catalysts
BWAY Positive Sentiment

Depressive symptoms during deep transcranial magnetic stimulation or sham treatment for obsessive-compulsive disorder

Key Takeaway: The study investigates the relationship between obsessive-compulsive disorder (OCD) and depressive symptoms in patients undergoing deep transcranial magnetic stimulation (dTMS). Results indicate that while both symptom types improved significantly, there was no predictive relationship between them. This suggests that depression symptoms may decrease with dTMS treatment for OCD, but monitoring is essential.
Price reaction · baseline $2.925 (2024-05-08T15:46:00.000Z) · hit during market hours · 3 other BWAY headline(s) in the window, move may be shared
day 0 close · peak
-2.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Both OCD and depression symptoms improved significantly.
  • dTMS shows promise as a treatment option for OCD.
  • The study provides insights into the relationship between OCD and depression.

CONCERNS & RISKS

  • A stable, cross-lagged relationship between OCD and depression was not supported.
  • Changes in OCD symptoms could not predict changes in depression symptoms.

Full Press Release Details

Background:

Evidence suggests that depressive symptoms tend to improve concurrently with obsessive-compulsive disorder (OCD) symptoms during cognitive behavioral therapy (CBT), despite depression not being the primary target of intervention. Studies examining the temporal or mediational relationships of OCD and depressive symptoms have indicated a bidirectional relationship, as prior levels of OCD symptoms influenced subsequent levels of depression, and vice versa. Deep transcranial magnetic stimulation ( dTMS ) has recently emerged as a treatment option for OCD. Whether dTMS affects depression symptoms similarly to CBT remains to be examined.

Objective:

The current study aims to examine the temporal precedence of change in obsessive-compulsive symptoms for change in depressive symptoms as well as the change of depressive symptoms for change in obsessive-compulsive symptoms in 94 patients randomized to either a 6-week course of dTMS or a sham control group, during treatment and at 4-week posttreatment follow up, using a CLPM approach.

Methods:

The current study employed a random intercept cross-lagged panel model (RI-CLPM) to examine the relationship of OCD and depression symptoms in 94 treatment refractory patients, undergoing dTMS or sham treatment.

Results:

Both OCD and depression symptoms improved significantly. However, a stable, cross-lagged relationship between the variables was not supported. Changes in one symptom domain could not be used to predict the other.

Conclusions:

When treating OCD with dTMS , depression symptoms appear likely to diminish but should be monitored throughout, and additional interventions applied if needed .

Full Article:

Frequently Asked Questions

What was the objective of the study?

The study aimed to examine the relationship between changes in OCD and depressive symptoms during dTMS treatment.

How many patients were involved in the study?

The study involved 94 treatment refractory patients.

What were the results of the dTMS treatment?

Both OCD and depression symptoms improved significantly with dTMS treatment.

Was there a predictive relationship between OCD and depression symptoms?

No, the study found no stable, cross-lagged relationship between the two symptoms.

What should be monitored during dTMS treatment?

Depression symptoms should be monitored throughout dTMS treatment for OCD.

Last updated: May 8, 2024